Mia focusses on the clinical decision, to recall or not to recall, in breast screening.
- Case-Wise recall suggestion: Suggests a decision for the entire case, the same as an expert mammographer
- Explanatory Regions of Interest: Relevant areas can be marked low false positive rate
- Flexible workflow integration: Mia is PACS agnostic and supports assisted single reading and blinded double reading workflows.
Product specifications Information source: Public
Last updated: Jan. 10, 2020
General
Product name Mia
Company Kheiron Medical Technologies
Subspeciality Breast
Modality Mammography
Disease targeted breast cancer
Key-features recall suggestion, suspicious region marking
Suggested use
Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time
Certification
CE Certified, Class unknown
FDA No or not yet
Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers